- Home
- EBS vs BME Comparison
EBS vs BME Comparison
Compare EBS & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- BME
- Stock Information
- Founded
- EBS 1998
- BME 2005
- Country
- EBS United States
- BME United States
- Employees
- EBS N/A
- BME N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- BME Trusts Except Educational Religious and Charitable
- Sector
- EBS Health Care
- BME Finance
- Exchange
- EBS Nasdaq
- BME Nasdaq
- Market Cap
- EBS 423.6M
- BME 487.9M
- IPO Year
- EBS 2006
- BME N/A
- Fundamental
- Price
- EBS $9.14
- BME $37.89
- Analyst Decision
- EBS Strong Buy
- BME
- Analyst Count
- EBS 2
- BME 0
- Target Price
- EBS $13.50
- BME N/A
- AVG Volume (30 Days)
- EBS 959.0K
- BME 34.0K
- Earning Date
- EBS 11-05-2025
- BME 01-01-0001
- Dividend Yield
- EBS N/A
- BME 6.26%
- EPS Growth
- EBS N/A
- BME N/A
- EPS
- EBS 2.53
- BME 1.44
- Revenue
- EBS $851,600,000.00
- BME N/A
- Revenue This Year
- EBS N/A
- BME N/A
- Revenue Next Year
- EBS $19.24
- BME N/A
- P/E Ratio
- EBS $3.62
- BME $28.37
- Revenue Growth
- EBS N/A
- BME N/A
- 52 Week Low
- EBS $4.02
- BME $35.53
- 52 Week High
- EBS $12.73
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- EBS 65.40
- BME 67.77
- Support Level
- EBS $8.58
- BME $35.95
- Resistance Level
- EBS $9.34
- BME $37.87
- Average True Range (ATR)
- EBS 0.38
- BME 0.39
- MACD
- EBS 0.10
- BME 0.13
- Stochastic Oscillator
- EBS 85.94
- BME 94.85
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.